GLIOBLASTOMA MULTIFORME MARKET OVERVIEW: KEY DEVELOPMENTS & EMERGING TRENDS

Glioblastoma Multiforme (GBM) is an aggressive and treatment-resistant form of brain cancer, originating from glial cells. It progresses rapidly, has a high recurrence rate, and presents significant challenges for conventional treatment approaches. Despite these obstacles, continuous advancements in research and therapeutic development are driving